Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway

about

Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway

Item

http://www.wikidata.org/entity/Q41623567

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Identification of microRNAs in ...... r receptor 1 signaling pathway

@en

type

Item

label

Identification of microRNAs in ...... r receptor 1 signaling pathway

@en

prefLabel

Identification of microRNAs in ...... r receptor 1 signaling pathway

@en

P1476

Identification of microRNAs in ...... r receptor 1 signaling pathway

@en

P2093

Hanping Wang

http://www.w3.org/2001/XMLSchema#string

Jie Tan

http://www.w3.org/2001/XMLSchema#string

Lanlan Ning

http://www.w3.org/2001/XMLSchema#string

Wei Ma

http://www.w3.org/2001/XMLSchema#string

Yanhong Kang

http://www.w3.org/2001/XMLSchema#string

Yi Ying

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Normalization of cDNA microarray data using wavelet regressions.

Rationale for co-targeting IGF-1R and ALK in ALK fusion-positive lung cancer

RNA interference and double-stranded-RNA-activated pathways.

Gene-guided gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive non-small cell lung cancer: an economic analysis

P304

2853-2862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4847

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28912847

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

P932

5585727

http://www.w3.org/2001/XMLSchema#string